Selenium (Se) is an essential trace element in human nutrition due to its presence, in the form of selenocysteine residue, in 25 selenoproteins. Selenoproteins participate in diverse biological processes, but their key roles are to regulate cellular redox homeostasis. These redox activities are modulated by the level and chemical form of dietary Se in a selenoprotein- and organ-specific manner. Selenoprotein status has been implicated in a variety of physiological processes and diseases, but the function of Se that attracted the most attention is its role in cancer. There are numerous studies, including clinical trials, which support the role of Se in cancer prevention, but there are also studies that found no such role. The consensus is that Se may be beneficial under conditions of low Se status, when selenoprotein levels are suboptimal, whereas this micronutrient is not effective in cancer prevention when Se levels are above that needed to saturate selenoprotein expression. Our research revealed a dual role the 15 kDa selenoprotein (Sep15) in cancer. We hypothesize that Sep15 and its homolog selenoprotein M (SelM) serve as redox gatekeepers for disulfide-rich proteins that pass through the endoplasmic reticulum. This hypothesis will be addressed using cell culture and mouse models. We will determine redox targets of Sep15 and SelM, characterize consequences of their deficiency, profile immunoglobulins in selenoprotein knockout mice and examine their maturation status. In addition, we found that high-throughput analyses of selenoproteins in a large panel of human cancer cell lines provides direct insights into the functions of these proteins in the context of human cancer, control of redox homeostasis and dependence of various cancer types on selenoproteins. We will characterize the human selenoproteome and selenocysteine machinery for their roles in human cancer by analyzing coexpression patterns and dependence of various cancer types on selenoproteins and drugs, and will link this information with genotype and expression patterns. This information will define the roles of selenoproteins in human cancer and provide critical information for the development of approaches for personalized use of dietary selenium to modulate cancer prevention and progression. Overall, these studies will provide critical insights into the role of selenium and selenoproteins in cancer.

Public Health Relevance

Mechanisms by which the trace element selenium affects cancer incidence are not known. We propose to functionally characterize selenoproteins that are thought to mediate the effect of selenium in cancer prevention and progression. We will also examine selenoprotein functions and regulation in the context of human cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA080946-14
Application #
8637934
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Perloff, Marjorie
Project Start
2001-04-01
Project End
2018-03-31
Budget Start
2014-05-23
Budget End
2015-03-31
Support Year
14
Fiscal Year
2014
Total Cost
$305,316
Indirect Cost
$123,593
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Romagné, Frédéric; Santesmasses, Didac; White, Louise et al. (2014) SelenoDB 2.0: annotation of selenoprotein genes in animals and their genetic diversity in humans. Nucleic Acids Res 42:D437-43
Hatfield, Dolph L; Tsuji, Petra A; Carlson, Bradley A et al. (2014) Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci 39:112-20
Labunskyy, Vyacheslav M; Hatfield, Dolph L; Gladyshev, Vadim N (2014) Selenoproteins: molecular pathways and physiological roles. Physiol Rev 94:739-77
Kasaikina, Marina V; Turanov, Anton A; Avanesov, Andrei et al. (2013) Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis. Carcinogenesis 34:1089-95
Tobe, Ryuta; Naranjo-Suarez, Salvador; Everley, Robert A et al. (2013) High error rates in selenocysteine insertion in mammalian cells treated with the antibiotic doxycycline, chloramphenicol, or geneticin. J Biol Chem 288:14709-15
Naranjo-Suarez, Salvador; Carlson, Bradley A; Tobe, Ryuta et al. (2013) Regulation of HIF-1? activity by overexpression of thioredoxin is independent of thioredoxin reductase status. Mol Cells 36:151-7
Malinouski, Mikalai; Kehr, Sebastian; Finney, Lydia et al. (2012) High-resolution imaging of selenium in kidneys: a localized selenium pool associated with glutathione peroxidase 3. Antioxid Redox Signal 16:185-92
Kasaikina, Marina V; Hatfield, Dolph L; Gladyshev, Vadim N (2012) Understanding selenoprotein function and regulation through the use of rodent models. Biochim Biophys Acta 1823:1633-42
Labunskyy, Vyacheslav M; Lee, Byung Cheon; Handy, Diane E et al. (2011) Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid Redox Signal 14:2327-36
Kim, Jin Young; Carlson, Bradley A; Xu, Xue-Ming et al. (2011) Inhibition of selenocysteine tRNA[Ser]Sec aminoacylation provides evidence that aminoacylation is required for regulatory methylation of this tRNA. Biochem Biophys Res Commun 409:814-9

Showing the most recent 10 out of 37 publications